Dire wolves — or really, wolves with traits like the extinct species — are back. But New York has plenty of its own ...

U niversity of Virginia President Jim Ryan’s Boston Marathon run to support the University's Alzheimer’s research and the ...

Novavax on Wednesday said the U.S. Food and Drug Administration has asked the company to commit to produce more data on its ...

Private businesses that give away all profits and also succeed as businesses are scarce; the Newman’s Own food branding ...

The drug could keep your pet around for longer—but some vets and ethicists worry that we might be barking up the wrong tree.

The global marketplace is here to stay. But global competition must take place on fair, transparent and enforceable terms, ...

CompanyOverview|NASDAQ:CLLS] Cellectis S.A. (NASDAQ: CLLS) is a clinical-stage biotechnology company focused on developing 'off-the-shelf' cancer immunotherapies using gene-editing technology.

To the Shareholders of Sinovac Biotech Ltd. and Other Stakeholders: The management of Sinovac Biotech Ltd. (NASDAQ: SVA, “SINOVAC” or the “Company”) recently received notice of its external auditor’s ...

Far beyond Harvard Yard, the university is a major economic engine for the region.

Another week and another big artificial intelligence round. All in all it was an active week with a half-dozen rounds of $100 ...

Scientists at the University of California, Riverside, have discovered how adult stem cells retain their regenerative power.

Glycolysis is an ancient metabolic activity. It consists of a set of reactions that convert glucose into energy. This central ...